Female Athlete Fertility Letter Calls for Protected Time and Support

A fertility specialist has called for paid, protected time off for female athletes undergoing fertility assessment or treatment, arguing that reproductive care remains outside recent improvements in sports insurance. The proposal came in a letter to the Guardian from Dr. Mireia Galian, medical director of IVI London.

Galian welcomed changes linked to the Carney review that are intended to improve coverage for pregnancy, contraception, menopause and conditions that disproportionately affect women. She argued that fertility still sits in a gap between health support and employment protection, particularly when competitive years overlap with age-related fertility decline.

The letter is an expert policy argument, not a clinical study or an announcement of new legal rights. It did not present data showing that elite training causes permanent infertility, specify an insurance package for egg freezing or predict litigation. Its concrete request was narrower: timely support, flexibility and protected time for assessment and treatment.

The Announced Insurance Changes Have a Defined Scope

The Women's Football Taskforce commissioned Loughborough University to work with insurers and brokers after Karen Carney's 2023 review of women's football. The changes announced in March 2026 were designed to address gaps involving pregnancy, contraception, menopause, other female health conditions and relative energy deficiency in sport, known as RED-S.

The work involved the British Insurance Brokers' Association and firms including Aon, Willis, Miller, Howden and Marsh. The Guardian reported that Aon would include miscarriage resulting from a sporting accident in its personal accident policies as standard. Other insurers were reviewing professional-sport products and terms.

That process is significant, but it is not a single nationwide policy that guarantees every athlete the same benefits. The announcement did not say that egg or embryo freezing, in-vitro fertilization or all fertility treatment would be funded. Galian's letter was written because she believed the emerging framework still left those needs unresolved.

The policy issue also extends beyond football. Athletes in individual sports, lower divisions or short-term contracts can have different employment arrangements, medical teams and insurance. A benefit negotiated in one league or tour cannot be assumed to exist across women's sport.

Menstrual Disruption Is a Health Signal, Not a Fertility Verdict

Low energy availability occurs when dietary energy does not adequately cover training demands and basic physiological needs. The 2023 International Olympic Committee consensus describes RED-S as a multifactorial syndrome that can affect reproductive function, bone health, metabolism, immunity, cardiovascular health, mental health and performance in athletes of any gender.

For female athletes, menstrual cycles can become irregular or stop when the hormonal system responds to prolonged or severe low energy availability. A BBC review reported that nearly two-thirds of female athletes experience interrupted periods, with high rates in endurance and aesthetic sports. An absent period can indicate that ovulation is not occurring, making conception difficult during that time.

That statistic does not mean nearly two-thirds of athletes become infertile. Exercise physiologist Emma O'Donnell told the BBC that disruption to periods and egg release is the clearest recognized fertility effect and should resolve after competition. The same report emphasized that definitive evidence on miscarriage and other long-term fertility outcomes remains limited and sometimes conflicting.

The IOC consensus similarly treats reproductive dysfunction as one potential RED-S outcome while noting that recovery differs among people and systems. Menstrual function may improve when energy availability is restored, but bone loss can take longer and may not fully reverse. Menstrual irregularity also has causes unrelated to RED-S, so diagnosis requires individual clinical assessment rather than an assumption based on body fat or training volume alone.

Fertility Protection Can Mean Different Things

Galian pointed to the overlap between peak competitive years and declining fertility with age. She argued that athletes trying to conceive may face additional difficulty when cycles are infrequent or absent and that fertility preservation should be discussed in time for a person to make an informed choice.

One existing sports policy offers a limited example. The Women's Tennis Association introduced a protected-ranking rule for players who temporarily leave competition for a fertility procedure, including egg or embryo freezing. The rule can preserve entry status when a player returns. It does not itself pay medical bills, guarantee income during absence or create a right that applies outside the WTA.

Protected time, insurance coverage and clinical care are therefore separate questions. A contract can prevent an athlete from losing her place while still leaving treatment costs uncovered. Insurance can cover a procedure without addressing selection pressure or scheduling. Medical access can exist while an athlete fears disclosing symptoms to a coach or employer.

Any broader policy would need clear eligibility, privacy protections, independent medical advice and transparent limits. It should also distinguish medically indicated treatment from elective fertility preservation without dismissing either as cosmetic. Those choices belong to athletes and qualified clinicians, not performance staff.

The Case for Support Does Not Require Medical Certainty

The evidence supports routine attention to menstrual health and low energy availability because both can affect current health and performance. It supports timely evaluation when periods become irregular, stop or are masked by hormonal contraception. It also supports research that follows athletes long enough to measure fertility and pregnancy outcomes rather than inferring them from menstrual status alone.

What the evidence does not support is a universal chain from hard training to hormonal collapse, assisted reproduction and permanent infertility. It does not show that a particular body-fat percentage causes lasting reproductive damage, or that most athletes with interrupted periods will need IVF. Those claims convert a real health concern into an unsupported prognosis.

Galian's proposal is strongest as a labor and access argument. Athletes should be able to seek assessment and make time-sensitive reproductive decisions without automatically sacrificing competition status or employment. The uncertainty in the science makes informed, confidential care more important, not less.

Recent insurance changes and the WTA rule show that sports organizations can redesign benefits around female health. They do not complete the work, and they do not prove that a single model fits every sport. Progress should be measured by the protections actually written into contracts and policies, not by predictions of biological catastrophe or inevitable lawsuits.